https://www.fortunebusinessinsights.com/blood-screening-market-102552
https://www.fortunebusinessinsights.com/blood-screening-market-102552
The global blood screening market was valued at USD 2.31 billion in 2018 and is expected to
reach USD 6.63 billion by 2032, growing at a compound annual rate of 7.9% over the
forecast period. In 2018, North America held the largest share of the market at 41.86%.
The global blood screening market has experienced steady growth and is projected to
expand significantly over the coming years. Rising demand for safe blood transfusions,
increasing prevalence of infectious diseases, and technological advancements in screening
methods are key factors driving this growth. North America currently leads the market due
to strong healthcare infrastructure and early adoption of advanced technologies, while other
regions are rapidly emerging as important contributors.
Learn more here:
https://www.fortunebusinessinsights.com/blood-screening-market-102552
Market Segmentation
1. By Product
• Reagents and Kits: Widely used for screening of infectious markers and dominating
due to their recurring use.
•
Instruments: Includes automated analyzers and devices for nucleic acid testing,
immunoassays, and rapid testing platforms.
• Software and Services: Growing in importance as data management and automation
become critical in blood banks and laboratories.
2. By Technology
• Nucleic Acid Testing (NAT): Highly sensitive technology increasingly adopted to
detect viral infections at early stages.
• Enzyme-Linked Immunosorbent Assay (ELISA): Extensively used and evolving with
chemiluminescent and advanced formats.
• Rapid Tests: Used for quick screening in resource-limited or emergency settings.
• Western Blotting and Next-Generation Sequencing: Applied for confirmatory and
advanced diagnostic purposes.
3. By Application
•
Infectious Disease Screening: Focused on detection of HIV, hepatitis, syphilis,
malaria, and other transfusion-transmissible infections.
• Blood Group Typing: Essential for ensuring compatibility in transfusions and
transplantation.
4. By End User
• Blood Banks: Major end users performing high volumes of routine screening.
• Hospitals and Clinics: Conduct testing for transfusions and patient care.
• Clinical Laboratories: Provide specialized testing services, often outsourcing from
smaller facilities.
list of key companies profiled:
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• BD
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc.
• Abbott
• QUOTIENT
Market Growth Drivers
The market is driven by increasing demand for safe blood transfusions, rising prevalence of
chronic and infectious diseases, and growing adoption of advanced molecular technologies.
Awareness initiatives by governments and organizations are encouraging stringent safety
protocols. Automation and digitalization are enhancing efficiency and accuracy in testing. In
addition, the growing need for early disease detection supports the integration of blood
screening in preventive healthcare.
Market Restraining Factors
High costs associated with advanced technologies limit adoption in low-resource settings.
Strict regulatory requirements can delay product launches and increase compliance costs.
Shortage of trained laboratory professionals poses challenges for widespread
implementation. Limited infrastructure in developing regions restricts accessibility to
advanced screening methods. Furthermore, alternative diagnostic approaches and limited
reimbursement policies can restrain growth.
Regional Analysis
• North America: Leads the market due to advanced healthcare infrastructure, strong
regulatory frameworks, and early adoption of innovative technologies.
• Europe: Maintains a significant share supported by strict safety standards,
government initiatives, and established blood banking networks.
• Asia–Pacific: Expected to grow rapidly due to rising population, increasing prevalence
of infectious diseases, expanding healthcare infrastructure, and government
investment in blood safety programs.
• Latin America: Witnessing steady growth as healthcare systems improve and
awareness about blood safety increases.
• Middle East & Africa: Showing gradual progress with growing demand for
transfusions and international collaborations to strengthen blood screening facilities.